How to use ACE-inhibitors, β-blockers, and newer therapies in AMI

Aldo Maggioni; Roberto Latini

doi:10.1016/s0002-8703(99)70341-8

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2005

Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers, Aldosterone Antagonists and Angiotensin Receptor Blockers in Heart Failure: Putting Guidelines into Practice

John J.V. McMurray, Alain Cohen‐Solal, Rainer Dietz, Eric J. Eichhorn, Leif Erhardt, Richard Hobbs, Henry Krum, Aldo Maggioni, Robert S. McKelvie, Ileana L. Piña, Jordi Soler‐Soler, Karl Swedberg

Article2001

Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers and Spironolactone in Heart Failure: Putting Guidelines Into Practice

John J.V. McMurray, Cohen‐Solal Alain, Rainer Dietz, Eichhorn Eric, Erhardt Leif, Richard Hobbs, Aldo Maggioni, Pina Ileana, Soler‐Soler Jordi, Karl Swedberg

Letter2020

ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19

Yueying Wang, Gary Tse, Guangping Li, Professor Gregory Lip, Tong Liu

Article1996

Myocardial Infarction: When and How Should We Initiate Treatment with ACE Inhibitors?

Roberto Latini, Aldo Maggioni, Giulio Zuanetti

Article2000

ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1

Annalisa Perna, Piero Ruggenenti, A. Testa, Belinda Spoto, Roberto Benini, V. Misefari, Giuseppe Remuzzi, Carmine Zoccali